INSIGHTS ON PHARMACEUTICAL LOGISTICS

  • Reducing Cost within Advanced Therapy Clinical Trials
    Reducing Cost within Advanced Therapy Clinical Trials

    The challenge for advanced therapy companies is that they need to develop a supply chain that delivers their therapy, at scale, without adding significantly to the cost of goods sold (COGS). In this case study, we’ll demonstrate how a company saw 55% cost savings across its distribution system, and increased visibility of its supply chain through meaningful data through partnering with Fisher BioServices and Fisher Clinical Services.

  • Top 3 Reasons Why A Direct-To-Patient Clinical Trial is Right For You
    Top 3 Reasons Why A Direct-To-Patient Clinical Trial is Right For You

    Patient-centricity has been a growing trend across the pharmaceutical and biotech industries for some time now. As the focus on precision and personalized medicine continues to increase, sponsors are looking for innovative ways to increase patient enrollment and compliance while reducing drug development timelines and costs. The direct-to-patient (DTP) model has emerged as a potential solution. This model illustrates a means by which a patient is able to receive his or her medication in the convenience of their home. In this article, we’ll share the top three challenges many sponsors face, and how a direct-to-patient pharmacy can provide solutions.

  • Managing Refrigerated vs. Frozen Drug Product: What’s The Big Deal?
    Managing Refrigerated vs. Frozen Drug Product: What’s The Big Deal?

    The most common storage is ultra-low temperature storage, but the fastest-growing is cryogenic, in vapor phase liquid nitrogen. This transition is huge. Chain of temperature data and chain of custody in handling is imperative to the pharmaceutical industry of today.  These additional factors partly explain the much higher cost of these therapies as well. The three primary issues are: capacity, regulatory, and risk. We’ll look briefly at all three.

  • Off-Site Storage Of Biological Specimens And Biologics For Risk Mitigation
    Off-Site Storage Of Biological Specimens And Biologics For Risk Mitigation

    Choosing an offsite storage facility means asking the right questions to determine if the storage provider has the appropriate risk mitigation infrastructure in place, beginning with a realistic threat assessment.

  • Conducting The Advanced Therapy Supply Chain Orchestra

    Conducting the advanced therapy supply chain orchestra is more than waving a stick at people – it is an “end to end”, complicated, inter-related system that requires controlled, consistent management. Following are some things you need to think about to develop the capability to provide a harmonious supply chain management system.

  • The Importance Of Inventory Management: Do You Know Where Your Samples Are?

    With the exciting advances in research and drug development, the importance of sample management has never been higher. If you have ever experienced sample management mishaps, we ask: Do you know where your samples are? In this article, we’ll explore some of the common causes of inventory mismanagement and best practices to guard against sample loss and near misses.

  • Controlling Complexity (Not Cost) Of Advanced Therapy Supply Chains

    Due to the short shelf life and clinical criticality of advanced therapies, their supply chains are often highly complex.  Once efficacy and safety is demonstrated, the focus of advanced therapy developers moves to controlling cost.  However, the biggest cost within the supply chain is caused by its complexity.  In this article, we will share why the advanced therapy supply chain is so complex and how this complexity correlates to cost.

  • Storing Biologics At Non-Traditional Temperatures

    Maintaining the appropriate storage temperature of biological material is critical for downstream use. However, due to the complexity of this material and its sensitivity to temperature we are seeing an increase in non-traditional storage temperature requests. In this article, we’ll explore some of the reasons why this is occurring and the associated challenges.

  • Development Of Qualified Cold Chain Solution For Vaccine Transport To Uganda

    Maintaining the cold chain is a challenge when handling biologics such as vaccines, particularly when the clinic is in a remote location. Learn more about how Fisher Bioservices developed a qualified cold chain solution to transport Ebola vaccines to Uganda.

More Insights On Pharmaceutical Logistics

PHARMACEUTICAL LOGISTICS SOLUTIONS

  • Arcos™ Block Management System
    Arcos™ Block Management System

    Minimize errors, increase productivity and keep your laboratory’s resources focused on what matters most—positive patient outcomes—with the Thermo Scientific™ Arcos™ Block Management System.

  • Flexsafe® 2D & 3D Pre-Designed Solutions For Storage And Shipping

    The superior strength and flexibility of Flexsafe® bags make them safe for critical liquid shipping applications. The robustness of Flexsafe® bags is proven by applying extensive qualification regimes that combine the most stringent standard ASTM D4169 testing and real shipping conditions.

  • Arcos™ Block Management System Brochure

    Protect precious patient tissue blocks from misplacement and loss with the Thermo Scientific™ Syntri™ Arcos™Block Management System. Designed to minimize errors, increase productivity and keep your laboratory’s resources focused on what matters most – positive patient outcomes.

  • Catalent Biologics: Delivering Therapies To Market Faster
    Catalent Biologics: Delivering Therapies To Market Faster

    Catalent Biologics is an integrated partner with expertise to get a biologic to market faster. The company has the passion to help its partners accelerate, simplify and de-risk their biologic therapies -- from development and manufacturing, to fill/finish, clinical supply and commercial launch.

  • Clinical Trial Packaging Solutions Balancing Cost, Time And Quality
    Clinical Trial Packaging Solutions Balancing Cost, Time And Quality

    Changes to the protocol such as dosage changes, increases or decreases in volumes, changes to expiry dates, or inclusion/exclusion of countries that weren’t part of the original plan can impact clinical trial packaging. You need a partner that can help you accurately identify and predict issues that might impact schedules, while remaining nimble to adjust to changes. Read how Fisher Clinical Services can  serve as a trusted advisor to help you strike the best balance of cost, time and quality.